- iSDaily Wednesday – March 14th, 2018 – Episode 042
On this episode of iSDaily Wednesday with The One True Niz and Paul Gordon, On NewsFire, the Cattle Car Guide Rally of 2018 On Skynetter, Google Helps Killer Drones On Liberty Tech, Printing Cars in China [...]The post iSDaily Wednesday – March 14th, 2018 – Episode 042 appeared first on iState. […]
Forget the arms race, it’s time to focus on the genetics race, and China, it appears is winning that race. China is embracing the technique of Preimplantation Genetic Diagnosis (PGD) to screen for undesirable children that might pass on bad genes. The science is essentially eugenics, but with more polite language. While still in the womb, the undesired life can be terminated, allowing couples to focus on putting their resources and effort into raising genetically preferable babies. The Chines are enthusiastically practicing this polite form of eugenics, promising the end of diseases within the next couple of generations.
There is spreading awareness in China of preimplantation genetic diagnosis (PGD), a procedure that helps couples undergoing in vitro fertilization (IVF) to avoid passing on genetic mutations that could cause disease or disability in their children. Fertility doctor Qiao typically refuses interview requests, but she’s concerned that people aren’t getting the message about PGD fast enough. “Now, more and more diseases can be stopped — if not immediately, in the generation after next,” she says…..
Early experiments are beginning to show how genome-editing technologies such as CRISPR might one day fix disease-causing mutations before embryos are implanted. But refining the techniques and getting regulatory approval will take years. PGD has already helped thousands of couples. And whereas the expansion of PGD around the world has generally been slow, in China, it is starting to explode.
China’s central government, known for its long-term thinking, has over the past decade stepped up efforts to bring high-quality health care to the people, and its current 5-year plan has made reproductive medicine, including PGD, a priority, an effort that Qiao is leading. Researchers are hunting down various mutations in the Chinese population that might be screened for in PGD. And well-equipped and powerful clinical-research groups, including Qiao’s, are stepping up efforts to improve the technology, increase awareness and bring down costs.
Comprehensive figures are difficult to come by, but estimates from leading PGD providers show that China’s use of the technique already outpaces that in the United States, and it is growing up to five times faster. Qiao’s clinic alone now performs more procedures with PGD each year than all of the United Kingdom.